Once inflammation is initiated by the tp53 mutation-induced dysbiosis, a vicious cycle may ensue where this inflammation then aggravates dysbiosis, similar to the inflammatory responses triggered by bacterial infections, genetic predisposition (IL10 or NEMO knockout mice), and chemical treatments (such as DSS) that can induce intestinal dysbiosis [63, 76]. Here, IKBKG is linked to bacterial infectious disease.